Tackling Thyroid Cancer in Europe-The Challenges and Opportunities

Area of Science:

• Endocrinology
• Oncology
• Public Health Policy

Background:

• Thyroid cancer (TC) is the most common endocrine malignancy, generally treatable and curable.
• Key challenges include enhancing TC knowledge, early detection, optimizing therapy, and minimizing overdiagnosis.
• Uncertainties persist regarding optimal patient management, referral center treatment, and personalized therapeutic strategies.

Purpose of the Study:

• To address critical challenges in thyroid cancer management.
• To identify actionable steps for effective responses at EU and member state levels.
• To leverage opportunities within EU initiatives like the Beating Cancer Plan and Cancer Mission.

Main Methods:

• Convened an expert panel discussion hosted by the European Alliance for Personalised Medicine (EAPM).
• Focused on elucidating current challenges in thyroid cancer care.
• Identified potential strategies for improving patient outcomes and healthcare system responses.

Main Results:

• Highlighted the need for improved infrastructure and funding for thyroid cancer research and care.
• Emphasized the importance of multi-stakeholder collaboration between national and European initiatives.
• Stressed the goal of complementing, supporting, and mutually reinforcing efforts to enhance patient care.

Conclusions:

• Enhanced infrastructure, dedicated funding, and robust collaboration are crucial for advancing thyroid cancer management.
• Strategic alignment with EU cancer initiatives can accelerate progress in patient care and outcomes.
• A coordinated, multi-stakeholder approach is essential to optimize the diagnosis and treatment of thyroid cancer.